Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Alaunos Therapeutics, Inc. (ZIOP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Postma Robert W (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 06/08/2023 |
4
| Hofmeister Robert (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 06/08/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 06/08/2023 |
4
| Huang James (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 06/08/2023 |
4
| Vieser Jaime (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 06/08/2023 |
4
| Weis Holger (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.48, valued at
$48k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| Deniger Drew (VP, Research and Development) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 305,000 options to buy
@ $2.11, valued at
$643.6k
|
|
| 09/19/2022 |
4
| Srivastava Abhishek K (See Remarks) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.11, valued at
$52.8k
|
|
| 09/19/2022 |
4
| Wong Michael (VP, Finance) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.11, valued at
$105.5k
|
|
| 09/19/2022 |
4
| Lackey Melinda (Senior Vice President, Legal) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 185,000 options to buy
@ $2.11, valued at
$390.4k
|
|
| 09/01/2022 |
4
| Boyle Kevin S. Sr. (CEO) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 18,750 shares
@ $2.41, valued at
$45.2k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Huang James (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0
Granted 100,000 options to buy
@ $0.82, valued at
$82k
|
|
| 06/24/2022 |
4
| Postma Robert W (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 100,000 options to buy
@ $0.82, valued at
$82k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Huang James (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0
Granted 100,000 options to buy
@ $0.82, valued at
$82k
|
|
| 06/24/2022 |
4
| Postma Robert W (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 100,000 options to buy
@ $0.82, valued at
$82k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Bowden Christopher (Director) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 100,000 options to buy
@ $0.82, valued at
$82k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Boyle Kevin S. Sr. (CEO) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 2,000,000 options to buy
@ $0.66, valued at
$1.3M
|
|
| 04/01/2022 |
4
| De Groot Eleanor (EVP, Operations) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $0.66, valued at
$231k
|
|
| 12/27/2021 |
4
| De Groot Eleanor (EVP, Operations) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Sold 20,132 shares
@ $1.27, valued at
$25.6k
|
|
| 12/13/2021 |
4
| Lackey Melinda (Senior Vice President, Legal) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Granted 370,000 options to buy
@ $1.22, valued at
$451.4k
|
|
| 11/17/2021 |
4
| Boyle Kevin S. Sr. (CEO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Bought 884 shares
@ $1.4, valued at
$1.2k
Bought 9,116 shares
@ $1.4, valued at
$12.8k
|
|
|
|
|